Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.

Elderly in rural areas have many skin issues needing targeted healthcare.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.

Stopping zolpidem improved hair loss caused by self-inflicted scalp injuries during sleep.

Baricitinib shows promise in treating severe hair loss.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Certain bacteria may influence alopecia areata risk, but skin bacteria don't mediate gut-skin effects.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Treating scalp issues in hair-pulling disorder helps hair regrow and reduces itch.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Altered hypothalamic activity may contribute to stress in alopecia areata patients.